• Title/Summary/Keyword: Trypanosoma evansi

Search Result 3, Processing Time 0.021 seconds

Oxidative Stress in the Heart of Rats Infected with Trypanosoma evansi

  • Baldissera, Matheus D.;Souza, Carine de F.;Bertoncheli, Claudia M.;da Silveira, Karine L.;Grando, Thirssa H.;Porto, Bianca C.Z.;Leal, Daniela B.R.;Da Silva, Aleksandro S.;Mendes, Ricardo E.;Stefani, Lenita M.;Monteiro, Silvia G.
    • Parasites, Hosts and Diseases
    • /
    • v.54 no.3
    • /
    • pp.247-252
    • /
    • 2016
  • This study was conducted to investigate the occurrence of oxidative stress in the heart tissue of rats infected with Trypanosoma evansi. Rats were divided into 2 groups (A and B) with 12 animals each, and further subdivided into 4 subgroups (A1 and A2, 6 animals/each; and B1 and B2, 6 animals/each). Animals in the groups B1 and B2 were subcutaneously inoculated with T. evansi. Thiobarbituric acid reactive substances (TBARS), superoxide dismutase activity (SOD), glutathione S-transferase activity (GST), reduced glutathione activity (GSH), and non-protein thiols (NPSH) in the heart tissue were evaluated. At day 5 and 15 post-infection (PI), an increase in the TBARS levels and a decrease in the SOD activity (P<0.05) were observed. GSH and GST activities were decreased in infected animals at day 15 PI (P<0.05). Considering the proper functioning of the heart, it is possible that the changes in the activity of these enzymes involved in the oxidative stress may be related, at least in part, in the pathophysiology of rats infected with T. evansi.

In Vitro Trypanocidal Activity of Macela (Achyrocline satureioides) Extracts against Trypanosoma evansi

  • Baldissera, Matheus D.;Oliveira, Camila B.;Zimmermann, Carine E.P.;Boligon, Aline A.;Athayde, Margareth Linde;Bolzan, Leandro P.;Vaucher, Rodrigo De A.;Santurio, Janio M.;Sagrillo, Michele R.;da Silva, Aleksandro Schafer;Monteiro, Silvia G.
    • Parasites, Hosts and Diseases
    • /
    • v.52 no.3
    • /
    • pp.311-315
    • /
    • 2014
  • The aim of this study was to verify the trypanocidal effectiveness of aqueous, methanolic, and ethanolic extracts of Achyrocline satureioides against Trypanosoma evansi in vitro. A. satureioides extracts, known as macela, were used on trypomastigotes at different concentrations (1, 5, 10, 50, 100, 500, and $1,000{\mu}g/ml$) and exposure times (0, 1, 3, 6, and 9 hr). A dose-dependent effect was observed when the 3 extracts were tested. The concentrations of 1, 5, and $10{\mu}g/ml$ were not able to kill trypomastigotes until 3 hr after exposure, and the highest concentrations (500 and $1,000{\mu}g/ml$) were able to kill all trypomastigotes after 1 hr. When the time of exposure was increased up to 9 hr, the concentrations at 50 and $100{\mu}g/ml$ were 100% effective to 3 extracts. The chemical analysis of the extracts revealed the presence of flavonoids, a trypanocidal compound already described. Based on the results, we can conclude that the A. satureioides extracts exhibit trypanocidal effects.

Susceptibility of Mice to Trypanosoma evansi Treated with Human Plasma Containing Different Concentrations of Apolipoprotein L-1

  • Da Silva, Aleksandro S.;Fanfa, Vinicius R.;Otto, Mateus A.;Gressler, Lucas T.;Tavares, Kaio C.S.;Lazarotto, Cicera R.;Tonin, Alexandre A.;Miletti, Luiz C.;Duarte, Marta M.M.F.;Monteiro, Silvia G.
    • Parasites, Hosts and Diseases
    • /
    • v.49 no.4
    • /
    • pp.427-430
    • /
    • 2011
  • The aim of this study was to test the susceptibility of mice to Trypanosoma evansi treated with human plasma containing different concentrations of apolipoprotein L-1 (APOL1). For this experiment, a strain of T. evansi and human plasma (plasmas 1, 2, and 3) from 3 adult males clinically healthy were used. In vivo test used 50 mice divided in 5 groups (A to E) with 10 animals in each group. Animals of groups B to E were infected, and then treated with 0.2 ml of human plasma in the following outline: negative control (A), positive control (B), treatment with plasma 1 (C), treatment with plasma 2(D), and treatment with plasma 3 (E). Mice treated with human plasma showed an increase in longevity of $40.9{\pm}0.3$ (C), $20{\pm}9.0$ (D) and $35.6{\pm}9.3$ (E) days compared to the control group (B) which was $4.3{\pm}0.5$ days. The number of surviving mice and free of the parasite (blood smear and PCR negative) at the end of the experiment was 90%, 0%, and 60% for groups C, D, and E, respectively. The quantification of APOL1 was performed due to the large difference in the treatments that differed in the source plasma. In plasmas 1, 2, and 3 was detected the concentration of 194, 99, and 115 mg/dl of APOL1, respectively. However, we believe that this difference in the treatment efficiency is related to the level of APOL1 in plasmas.